Puma Biotechnology Inc short interest in 2021
In 2021, Puma Biotechnology Inc's disclosed short interest ran from 12.27% of shares outstanding on 15 Jan 2021 to 7.26% on 31 Dec 2021, a change of -5.01 percentage points. The year's high was 12.38% on 29 Jan 2021 and its low 5.95% on 29 Oct 2021, averaging 8.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.76 days on 30 Apr 2021. Full history: Puma Biotechnology Inc.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 12.27% (15 Jan 2021)
- End of year
- 7.26% (31 Dec 2021)
- Change
- -5.01 pp
- High
- 12.38% (29 Jan 2021)
- Low
- 5.95% (29 Oct 2021)
- Average
- 8.89%
- Highest days to cover
- 19.76 (30 Apr 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 12.27% | 14.56 | |
| 29 Jan 2021 | 12.38% | 10.20 | |
| 12 Feb 2021 | 11.83% | 11.96 | |
| 26 Feb 2021 | 12.27% | 16.69 | results (8-K) |
| 15 Mar 2021 | 12.29% | 15.95 | 10-K filed |
| 31 Mar 2021 | 12.28% | 17.18 | |
| 15 Apr 2021 | 11.57% | 15.31 | |
| 30 Apr 2021 | 10.22% | 19.76 | |
| 14 May 2021 | 10.19% | 14.18 | 10-Q filed, results (8-K) |
| 28 May 2021 | 9.56% | 19.46 | |
| 15 Jun 2021 | 9.33% | 12.72 | |
| 30 Jun 2021 | 6.68% | 4.52 | |
| 15 Jul 2021 | 7.16% | 7.62 | |
| 30 Jul 2021 | 7.54% | 13.63 | |
| 13 Aug 2021 | 7.22% | 4.06 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 7.04% | 8.75 | |
| 15 Sep 2021 | 7.01% | 10.20 | |
| 30 Sep 2021 | 6.64% | 6.25 | |
| 15 Oct 2021 | 6.14% | 5.45 | |
| 29 Oct 2021 | 5.95% | 5.41 | |
| 15 Nov 2021 | 6.20% | 2.07 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 7.58% | 4.03 | |
| 15 Dec 2021 | 6.82% | 3.18 | |
| 31 Dec 2021 | 7.26% | 6.48 |
See also: Puma Biotechnology Inc's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.